Discovery Projects - Grant ID: DP0665794

Funding Activity

Website
http://dataportal.arc.gov.au/NCGP/Web/Grant/Grant/DP0665794

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Functionalised MMP Inhibitors as Radiodiagnostic, Radiotherapeutic, and Radiation-Sensitising Agents for Metastatic Cancer. Identifying and treating malignant cancers is one of the major challenges facing the scientific and medical communities. In order to minimise side effects that accompany most treatments of cancer it is necessary to find ways of targeting the therapy to tumours and away from healthy organs. A difference between tumours and healthy tissues is the amount of the proteins (called MMPs) that tumours use to break out of their surroundings, to break into and out of the blood system, and to establish new colonies of cancer cells or metastases. This difference also distinguishes the most aggressive cancers. The purpose of this project is to develop means of identifying and targeting cancers using molecules that bind to these MMP proteins.

Funded Activity Details

Start Date: 11-05-2006

End Date: 10-05-2009

Funding Scheme: Discovery Projects

Funding Amount: $342,000.00

Funder: Australian Research Council

Research Topics

ANZSRC Field of Research (FoR)

Bioinorganic Chemistry | Biological And Medical Chemistry | Inorganic Chemistry | Radiotherapy And Nuclear Medicine

ANZSRC Socio-Economic Objective (SEO)

Diagnostics | Treatments (e.g. chemicals, antibiotics) | Chemical sciences |

Other Keywords

Bioinorganic Chemistry | Biological And Medical Chemistry | Chemical sciences | Diagnostics | Inorganic Chemistry | Radiotherapy And Nuclear Medicine | Treatments (e.g. chemicals, antibiotics)

Related Links